391.50MMarket Cap-4338P/E (TTM)
7.875High7.540Low8.17KVolume7.780Open7.670Pre Close63.00KTurnover0.03%Turnover RatioLossP/E (Static)50.98MShares18.40052wk High1.70P/B225.48MFloat Cap4.42052wk Low--Dividend TTM29.36MShs Float47.170Historical High--Div YieldTTM4.37%Amplitude4.420Historical Low7.713Avg Price1Lot Size
enGene Holdings Stock Forum
Detalimogene Demonstrates 71% Complete Response Rate at Any Time in Preliminary Analysis of LEGEND Pivotal Cohort
Data from pivotal cohort demonstrate compelling clinical activity, consistent with Phase 1 results
Favorable tolerability profile with no drug-related discontinuations
Detalimogene's profile to date supports its potential as a foundational therapy for NMIBC
enGene to host a conference call to discuss preliminary data today at 8:00 a.m. ET
enGene Hold...
$Aptevo Therapeutics (APVO.US)$
$enGene Holdings (ENGN.US)$
$Trxade Health (MEDS.US)$
My next high risk investment is $WeBuy Global (WBUY.US)$. They have until Monday to get their stock over a 1.00 or delisting procedur...
No comment yet